Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Section Head Facial Plastic and Microvascular Surgery, Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.
Laryngoscope. 2020 Nov;130(11):2589-2592. doi: 10.1002/lary.28540. Epub 2020 Feb 19.
OBJECTIVES/HYPOTHESIS: To evaluate the efficacy and reconstructive applications of angular vessel microvascular anastomosis in free-tissue transfer.
Retrospective cohort study.
A study of patients treated from January 2010 to July 2017 was performed. Four hundred thirty patients undergoing free-tissue transfer at the Cleveland Clinic by a single reconstructive surgeon were reviewed. Patients in whom free-tissue transfer was performed using angular vessels were included. Patients in whom free-tissue transfer was performed using another vascular supply of the head and neck were excluded. Primary outcome was free-flap failure. Secondary outcomes included other postoperative complications and hospital length of stay.
Thirty-one patients underwent free-tissue transfer with microvascular anastomosis to the angular vessels during the study period. Seventy-one percent of patients underwent reconstruction immediately following tumor ablation. A variety of primary subsites were reconstructed; 58% underwent nasal reconstruction, 16% orbit/skull base reconstruction, 13% palatal reconstruction, 6% maxillary reconstruction, and 6% mandible reconstruction. Eighty-seven percent of patients underwent free-tissue transfer from an anterolateral thigh donor site. Ninety-seven percent of patients had successful free-tissue transfer with a viable flap during the follow-up period; only one patient experienced flap failure attributed to vascular insufficiency. Average length of stay was 4.7 days, and the most common length of stay was 3 days.
The angular vessels provide excellent arterial supply and venous drainage to serve as a viable option for microvascular anastomosis during free-tissue transfer for head and neck reconstructive surgery. They are an ideal vascular source for central face and skull base reconstruction.
NA Laryngoscope, 130:2589-2592, 2020.
目的/假设:评估角血管显微血管吻合在游离组织转移中的疗效和重建应用。
回顾性队列研究。
对 2010 年 1 月至 2017 年 7 月期间在克利夫兰诊所接受治疗的患者进行了一项研究。共回顾了 430 例由同一位重建外科医生行游离组织转移的患者。纳入了使用角血管进行游离组织转移的患者。排除了使用头颈部其他血管供应进行游离组织转移的患者。主要结局是游离皮瓣失败。次要结局包括其他术后并发症和住院时间。
在研究期间,31 例患者接受了角血管显微血管吻合游离组织转移。71%的患者在肿瘤消融后立即进行重建。重建的主要部位包括 58%的鼻重建、16%的眼眶/颅底重建、13%的腭重建、6%的上颌重建和 6%的下颌重建。87%的患者来自股前外侧供区。97%的患者在随访期间成功进行了游离组织转移,皮瓣存活;只有 1 例患者因血管功能不全导致皮瓣失败。平均住院时间为 4.7 天,最常见的住院时间为 3 天。
角血管为头颈部重建手术中的游离组织转移提供了良好的动脉供应和静脉引流,是显微血管吻合的可行选择。它们是中面部和颅底重建的理想血管来源。
无。喉科学,130:2589-2592,2020。